Decoy Therapeutics (DCOY) Retained Earnings (2015 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Retained Earnings of $100.5 million for Q1 2026, up 20.13% year-over-year from $83.7 million in Q1 2025, and little changed quarter-over-quarter from $100.3 million in Q4 2025.
Decoy Therapeutics (DCOY) Retained Earnings (2015 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Retained Earnings for 12 consecutive years, with $100.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 20.13% year-over-year to $100.5 million; the TTM figure through Mar 2026 stood at $100.5 million (up 20.13% YoY), while the FY2025 annual figure was $100.3 million, up 222.47% from the prior year.
- Retained Earnings was little changed at $100.5 million in Q1 2026 per DCOY's latest filing, from $100.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $100.5 million in Q1 2026 and bottomed at -$84.6 million in Q2 2025.
- Historically, Retained Earnings has averaged $2.1 million across 5 years, with a median of -$43.0 million in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings surged 437.0% — and 2023, when it tumbled 201.92%.
- Decoy Therapeutics' Retained Earnings stood at -$63.8 million in 2022, then soared by 227.94% to $81.6 million in 2023, then tumbled by 200.35% to -$81.9 million in 2024, then surged by 222.47% to $100.3 million in 2025, then advanced by 0.21% to $100.5 million in 2026.
- Business Quant data shows DCOY's Retained Earnings at $100.5 million in Q1 2026, $100.3 million in Q4 2025, and $89.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -6.33 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.57 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 4.38 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 20.91 Bn |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | 103.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 103.36 Mn |
| Mar 31, 2026 | 100.54 Mn |
| Dec 31, 2025 | 100.33 Mn |
| Sep 30, 2025 | 89.71 Mn |
| Jun 30, 2025 | -84.59 Mn |
| Mar 31, 2025 | 83.69 Mn |
| Dec 31, 2024 | -81.92 Mn |
| Sep 30, 2024 | 83.38 Mn |
| Jun 30, 2024 | -79.49 Mn |
| Mar 31, 2024 | -78.06 Mn |
| Dec 31, 2023 | 81.64 Mn |
| Sep 30, 2023 | -75.47 Mn |
| Jun 30, 2023 | -73.02 Mn |
| Mar 31, 2023 | -69.15 Mn |
| Dec 31, 2022 | -63.81 Mn |
| Sep 30, 2022 | 74.05 Mn |
| Jun 30, 2022 | -43.02 Mn |
| Mar 31, 2022 | 71.72 Mn |
| Dec 31, 2021 | -32.20 Mn |
| Sep 30, 2021 | -28.09 Mn |